Study: Many cancer drugs unproven 5 years after accelerated approval
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
“Five years after the initial accelerated approval, you should have a definitive answer,” said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. “Thousands of people are getting those drugs. That seems a mistake if we don’t know whether they work or not.”
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce better evidence before gaining full approval.
Related articles
FTX customers to get money back after catastrophic crypto collapse
FTX says that nearly all of its customers will receive the money back that they are owed, two years2024-05-09Mexico's presidential candidates discuss social spending, climate change in 2nd debate
MEXICO CITY (AP) — Mexico’s leading presidential candidate repeatedly touted the social programs of2024-05-09Musiala, Wirtz following in footsteps of Messi, Modric
The enchanting flow of two genius-like youngsters has triggered hopes of creating a satisfying UEFA2024-05-09Seasonal 'rocket chasers' ignite aerospace tourism boom in China
At homestays along the Qishui Bay in Longlou township, visitors can watch rocket launches from balco2024-05-09Lithuania defends banning Russian and Belarusian observers from monitoring upcoming election
VILNIUS, Lithuania (AP) — Lithuania defended Wednesday the decision not to allow Russian and Belarus2024-05-09Harbin war museum sees soaring visits
Harbin, capital of Heilongjiang province, arguably this winter's hottest travel destination, has2024-05-09
atest comment